Abiopharma

News list

Schmid John P. 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

Full text

News bot Jan. 8, 2026, 9:07 p.m.
🔍 Schmid John P. (Executive)

Company: ANAPTYSBIO, INC (ANAB)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 9,500
Detailed Transactions and Holdings:
- Acquired 5,500 shares of Stock Option (right to buy) at $43.91 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-05 | equity_swap_involved: 0 | shares_owned_after: 5,500.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 4,000 shares of Restricted Stock Unit (Derivative)
  Date: 2026-01-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,000.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.